New approaches to treating cancer with off-the-shelf immunostimulatory bispecific antibodies
Bispecific antibodies – manufactured drugs that can bind to two different tumor antigens – inhibit cancer growth by hitting multiple targets simultaneously. Now, three Johns Hopkins res…
